why choose us

Course: Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021

CME Credits: 1.00

Released: 2021-12-22

As of August 17, 2021, the US Centers for Disease Control and Prevention (CDC) reported that 168.7 million people in the US, more than half of the US population, had received full doses of SARS-CoV-2 vaccines. This study evaluates whether estimated vaccine effectiveness against infection changes over time to help inform public health policy and clinical practices.
This case-control study was approved by the Sterling institutional review board. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology () reporting guideline. Informed consent was waived by the institutional review board because of the use of limited retrospective data that was already collected.


Educational Objective
To identify the key insights or developments described in this article


View Full Course